- Home
- IRON vs IDT Comparison
IRON vs IDT Comparison
Compare IRON & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- IDT
- Stock Information
- Founded
- IRON 2017
- IDT 1990
- Country
- IRON United States
- IDT United States
- Employees
- IRON N/A
- IDT N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- IDT Telecommunications Equipment
- Sector
- IRON Health Care
- IDT Telecommunications
- Exchange
- IRON Nasdaq
- IDT Nasdaq
- Market Cap
- IRON 1.4B
- IDT 1.2B
- IPO Year
- IRON N/A
- IDT 1996
- Fundamental
- Price
- IRON $59.46
- IDT $49.32
- Analyst Decision
- IRON Strong Buy
- IDT
- Analyst Count
- IRON 10
- IDT 0
- Target Price
- IRON $72.00
- IDT N/A
- AVG Volume (30 Days)
- IRON 431.6K
- IDT 100.0K
- Earning Date
- IRON 11-12-2024
- IDT 12-02-2024
- Dividend Yield
- IRON N/A
- IDT 0.41%
- EPS Growth
- IRON N/A
- IDT 60.76
- EPS
- IRON N/A
- IDT 2.54
- Revenue
- IRON N/A
- IDT $1,205,778,000.00
- Revenue This Year
- IRON N/A
- IDT N/A
- Revenue Next Year
- IRON N/A
- IDT N/A
- P/E Ratio
- IRON N/A
- IDT $19.44
- Revenue Growth
- IRON N/A
- IDT N/A
- 52 Week Low
- IRON $25.60
- IDT $27.09
- 52 Week High
- IRON $77.60
- IDT $52.35
- Technical
- Relative Strength Index (RSI)
- IRON 58.39
- IDT 61.80
- Support Level
- IRON $63.21
- IDT $45.77
- Resistance Level
- IRON $68.73
- IDT $52.35
- Average True Range (ATR)
- IRON 3.49
- IDT 1.25
- MACD
- IRON 0.52
- IDT -0.09
- Stochastic Oscillator
- IRON 61.25
- IDT 53.95
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About IDT IDT Corporation Class B
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.